The pathogenesis of ankylosing spondylitis

Area of Science:

• Rheumatology
• Immunology
• Genetics

Background:

• Ankylosing spondylitis (AS) is a chronic inflammatory condition impacting the axial skeleton and sacroiliac joints.
• Familial associations, particularly with human leukocyte antigen (HLA)-B27, are known, but the precise pathogenic mechanisms are ill-defined.
• The molecular basis for AS's characteristic joint involvement requires further investigation.

Purpose of the Study:

• To review current literature on the origins and pathophysiology of ankylosing spondylitis.
• To focus on genetic and molecular associations, pathomechanisms, and potential triggers.
• To highlight the need for a better understanding of AS initiation for improved therapeutic strategies.

Main Methods:

• Review of existing scientific literature on ankylosing spondylitis.
• Analysis of genetic factors, including HLA-B27.
• Examination of proposed molecular and environmental triggers and immune system involvement.

Main Results:

• Current theories on HLA-B27 association include arthritogenic peptide presentation, autoimmune stimulation, and altered microbial tolerance.
• Immune effectors involved are CD4+, CD8+, and natural killer cells, showing site-specific heterogeneity.
• Biomechanical stress and environmental factors like infection are considered potential triggers, possibly via molecular mimicry.

Conclusions:

• Understanding the molecular sequence initiating AS is crucial for developing targeted therapies.
• Improved knowledge can lead to more effective treatments with fewer side effects than broad immunomodulation.
• Further research into AS pathogenesis promises advancements in patient care and disease management.